BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Weichert JP, Clark PA, Kandela IK, Vaccaro AM, Clarke W, Longino MA, Pinchuk AN, Farhoud M, Swanson KI, Floberg JM, Grudzinski J, Titz B, Traynor AM, Chen HE, Hall LT, Pazoles CJ, Pickhardt PJ, Kuo JS. Alkylphosphocholine analogs for broad-spectrum cancer imaging and therapy. Sci Transl Med 2014;6:240ra75. [PMID: 24920661 DOI: 10.1126/scitranslmed.3007646] [Cited by in Crossref: 71] [Cited by in F6Publishing: 73] [Article Influence: 8.9] [Reference Citation Analysis]
Number Citing Articles
1 Carlson PM, Patel RB, Birstler J, Rodriquez M, Sun C, Erbe AK, Bates AM, Marsh I, Grudzinski J, Hernandez R, Pieper AA, Feils AS, Rakhmilevich AL, Weichert JP, Bednarz BP, Sondel PM, Morris ZS. Radiation to all macroscopic sites of tumor permits greater systemic antitumor response to in situ vaccination. J Immunother Cancer 2023;11. [PMID: 36639155 DOI: 10.1136/jitc-2022-005463] [Reference Citation Analysis]
2 Pinchuk AN, Rampy MA, Longino MA, Durkee BY, Counsell RE, Weichert JP. Effect of Polar Head Group Modifications on the Tumor Retention of Phospholipid Ether Analogs: Role of the Quaternary Nitrogen. Pharmaceutics 2023;15. [PMID: 36678801 DOI: 10.3390/pharmaceutics15010171] [Reference Citation Analysis]
3 Muthukumar S, Darden J, Crowley J, Witcher M, Kiser J. A Comparison of PET Tracers in Recurrent High-Grade Gliomas: A Systematic Review. Int J Mol Sci 2022;24. [PMID: 36613852 DOI: 10.3390/ijms24010408] [Reference Citation Analysis]
4 Potluri HK, Ferreira CA, Grudzinski J, Massey C, Aluicio-Sarduy E, Engle JW, Kwon O, Marsh IR, Bednarz BP, Hernandez R, Weichert JP, McNeel DG. Antitumor efficacy of 90Y-NM600 targeted radionuclide therapy and PD-1 blockade is limited by regulatory T cells in murine prostate tumors. J Immunother Cancer 2022;10:e005060. [PMID: 36002185 DOI: 10.1136/jitc-2022-005060] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Caers J, Duray E, Vrancken L, Marcion G, Bocuzzi V, De Veirman K, Krasniqi A, Lejeune M, Withofs N, Devoogdt N, Dumoulin M, Karlström AE, D’huyvetter M. Radiotheranostic Agents in Hematological Malignancies. Front Immunol 2022;13:911080. [DOI: 10.3389/fimmu.2022.911080] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Grudzinski JJ, Hall LT, Cho S, Liu G, Traynor A, Lee MH, Longino M, Pinchuk A, Jaskowiak C, Bednarz B, Weichert J, Kuo JS. Clinical Imaging and Dosimetry of a Pan-Cancer Targeting Alkylphosphocholine Analog, [124I]I-NM404. Radiation 2022;2:215-27. [DOI: 10.3390/radiation2020015] [Reference Citation Analysis]
7 Muto J, Mine Y, Nishiyama Y, Murayama K, Yamada S, Kojima D, Hayakawa M, Adachi K, Hasegawa M, Lee JYK, Hirose Y. Intraoperative Real-Time Near-Infrared Image-Guided Surgery to Identify Intracranial Meningiomas via Microscope. Front Neurosci 2022;16:837349. [DOI: 10.3389/fnins.2022.837349] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Schroeder HW, Hall LT. Molecular Imaging of Brain Metastases with PET. Metastasis 2022. [DOI: 10.36255/exon-publications.metastasis.brain-metastases] [Reference Citation Analysis]
9 Onate AJ, Clark PA, Morris ZS. Using Radiation Therapy to Prime and Propagate an Anti-tumor Immune Response Against Brain Tumors. Neuromolecular Med 2022;24:3-7. [PMID: 34081276 DOI: 10.1007/s12017-021-08668-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Sheikh A, Fatima S, Khurshid Z, Chiragh Z. Theranostics of Hematologic Disorders. Nuclear Medicine and Immunology 2022. [DOI: 10.1007/978-3-030-81261-4_16] [Reference Citation Analysis]
11 Carlson PM, Morris ZS. Translational Development and Testing of Theranostics in Combination with Immunotherapies. Nuclear Medicine and Immunology 2022. [DOI: 10.1007/978-3-030-81261-4_12] [Reference Citation Analysis]
12 Neira S, Gago-Arias A, Gónzalez-Crespo I, Guiu-Souto J, Pardo-Montero J. Development of a Compartmental Pharmacokinetic Model for Molecular Radiotherapy with 131I-CLR1404. Pharmaceutics 2021;13:1497. [PMID: 34575575 DOI: 10.3390/pharmaceutics13091497] [Reference Citation Analysis]
13 Jagodinsky JC, Morris ZS. Priming and Propagating Anti-tumor Immunity: Focal Hypofractionated Radiation for in Situ Vaccination and Systemic Targeted Radionuclide Theranostics for Immunomodulation of Tumor Microenvironments. Semin Radiat Oncol 2020;30:181-6. [PMID: 32381297 DOI: 10.1016/j.semradonc.2019.12.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
14 Magee K, Marsh IR, Turek MM, Grudzinski J, Aluicio-Sarduy E, Engle JW, Kurzman ID, Zuleger CL, Oseid EA, Jaskowiak C, Albertini MR, Esbona K, Bednarz B, Sondel PM, Weichert JP, Morris ZS, Hernandez R, Vail DM. Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative (companion dog) setting. PLoS One 2021;16:e0255798. [PMID: 34383787 DOI: 10.1371/journal.pone.0255798] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Patel RB, Hernandez R, Carlson P, Grudzinski J, Bates AM, Jagodinsky JC, Erbe A, Marsh IR, Arthur I, Aluicio-Sarduy E, Sriramaneni RN, Jin WJ, Massey C, Rakhmilevich AL, Vail D, Engle JW, Le T, Kim K, Bednarz B, Sondel PM, Weichert J, Morris ZS. Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade. Sci Transl Med 2021;13:eabb3631. [PMID: 34261797 DOI: 10.1126/scitranslmed.abb3631] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 15.0] [Reference Citation Analysis]
16 Clark PA, Sriramaneni RN, Bates AM, Jin WJ, Jagodinsky JC, Hernandez R, Le T, Jeffery JJ, Marsh IR, Grudzinski JJ, Aluicio-Sarduy E, Barnhart TE, Anderson BR, Chakravarty I, Arthur IS, Kim K, Engle JW, Bednarz BP, Weichert JP, Morris ZS. Low-Dose Radiation Potentiates the Propagation of Anti-Tumor Immunity against Melanoma Tumor in the Brain after In Situ Vaccination at a Tumor outside the Brain. Radiat Res 2021;195:522-40. [PMID: 33826741 DOI: 10.1667/RADE-20-00237.1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Carlson PM, Mohan M, Patel RB, Birstler J, Nettenstrom L, Sheerar D, Fox K, Rodriguez M, Hoefges A, Hernandez R, Zahm C, Kim K, McNeel DG, Weichert J, Morris ZS, Sondel PM. Optimizing Flow Cytometric Analysis of Immune Cells in Samples Requiring Cryopreservation from Tumor-Bearing Mice. J Immunol 2021:ji2000656. [PMID: 34261667 DOI: 10.4049/jimmunol.2000656] [Reference Citation Analysis]
18 Rafael MS, Cohen-Gogo S, Irwin MS, Vali R, Shammas A, Morgenstern DA. Theranostics in Neuroblastoma. PET Clin 2021;16:419-27. [PMID: 34053585 DOI: 10.1016/j.cpet.2021.03.006] [Reference Citation Analysis]
19 Schupper AJ, Rao M, Mohammadi N, Baron R, Lee JYK, Acerbi F, Hadjipanayis CG. Fluorescence-Guided Surgery: A Review on Timing and Use in Brain Tumor Surgery. Front Neurol 2021;12:682151. [PMID: 34220688 DOI: 10.3389/fneur.2021.682151] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
20 Saini A, Singh J, Kumar S. Optically superior fluorescent probes for selective imaging of cells, tumors, and reactive chemical species. Org Biomol Chem 2021;19:5208-36. [PMID: 34037048 DOI: 10.1039/d1ob00509j] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Jagodinsky JC, Jin WJ, Bates AM, Hernandez R, Grudzinski JJ, Marsh IR, Chakravarty I, Arthur IS, Zangl LM, Brown RJ, Nystuen EJ, Emma SE, Kerr C, Carlson PM, Sriramaneni RN, Engle JW, Aluicio-Sarduy E, Barnhart TE, Le T, Kim K, Bednarz BP, Weichert JP, Patel RB, Morris ZS. Temporal analysis of type 1 interferon activation in tumor cells following external beam radiotherapy or targeted radionuclide therapy. Theranostics 2021;11:6120-37. [PMID: 33995649 DOI: 10.7150/thno.54881] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
22 Hall LT, Titz B, Baidya N, van der Kolk AG, Robins HI, Otto M, Perlman SB, Weichert JP, Kuo JS. [124I]CLR1404 PET/CT in High-Grade Primary and Metastatic Brain Tumors. Mol Imaging Biol 2020;22:434-43. [PMID: 31183841 DOI: 10.1007/s11307-019-01362-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
23 Shahi A, Weiss GE, Bhattacharya S, Baiu DC, Marino R, Pula T, Callander NS, Asimakopoulos F, Otto M. Targeted treatment of multiple myeloma with a radioiodinated small molecule radiopharmaceutical. Leuk Lymphoma 2021;62:1518-21. [PMID: 33502270 DOI: 10.1080/10428194.2021.1876858] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Schupper AJ, Yong RL, Hadjipanayis CG. The Neurosurgeon's Armamentarium for Gliomas: An Update on Intraoperative Technologies to Improve Extent of Resection. J Clin Med 2021;10:E236. [PMID: 33440712 DOI: 10.3390/jcm10020236] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
25 Schupper AJ, Hadjipanayis C. Use of Intraoperative Fluorophores. Neurosurg Clin N Am 2021;32:55-64. [PMID: 33223026 DOI: 10.1016/j.nec.2020.08.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Schipmann-Miletić S, Stummer W. Image-Guided Brain Surgery. Recent Results Cancer Res 2020;216:813-41. [PMID: 32594408 DOI: 10.1007/978-3-030-42618-7_26] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
27 Timko L, Pisárčik M, Mrva M, Garajová M, Juhásová A, Mojžiš J, Mojžišová G, Bukovský M, Devínsky F, Lukáč M. Synthesis, physicochemical properties and biological activities of novel alkylphosphocholines with foscarnet moiety. Bioorg Chem 2020;104:104224. [PMID: 32892068 DOI: 10.1016/j.bioorg.2020.104224] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
28 Velten A, Uselmann A, Prajapati S, Bredfeldt J, Mackie T, Eliceiri K. Transient Room Lighting for Ambient Light Multiphoton Microscopy.. [DOI: 10.1101/2020.08.04.236364] [Reference Citation Analysis]
29 Sgouros G, Bodei L, McDevitt MR, Nedrow JR. Radiopharmaceutical therapy in cancer: clinical advances and challenges. Nat Rev Drug Discov 2020;19:589-608. [PMID: 32728208 DOI: 10.1038/s41573-020-0073-9] [Cited by in Crossref: 160] [Cited by in F6Publishing: 169] [Article Influence: 53.3] [Reference Citation Analysis]
30 Ahmed H, Carter KC, Williams RAM. Structure and Antiparasitic Activity Relationship of Alkylphosphocholine Analogues against Leishmania donovani. Microorganisms 2020;8:E1117. [PMID: 32722326 DOI: 10.3390/microorganisms8081117] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
31 Bedir M, Thomadsen B, Bednarz B. Development and characterization of a handheld radiation detector for radio-guided surgery. Radiation Measurements 2020;135:106362. [DOI: 10.1016/j.radmeas.2020.106362] [Reference Citation Analysis]
32 Jagodinsky JC, Harari PM, Morris ZS. The Promise of Combining Radiation Therapy With Immunotherapy. Int J Radiat Oncol Biol Phys 2020;108:6-16. [PMID: 32335187 DOI: 10.1016/j.ijrobp.2020.04.023] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 16.7] [Reference Citation Analysis]
33 Vail DM, LeBlanc AK, Jeraj R. Advanced Cancer Imaging Applied in the Comparative Setting. Front Oncol 2020;10:84. [PMID: 32117739 DOI: 10.3389/fonc.2020.00084] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
34 Berrones‐reyes JC, Muñoz‐flores BM, Uscanga‐palomeque AC, Santillán R, Del Angel‐mosqueda C, Nobis D, Cochrane MA, Magennis SW, Jiménez‐pérez VM. Two‐Photon Detection of Organotin Schiff Base Complexes in Cancer Cells. ChemistrySelect 2020;5:1623-7. [DOI: 10.1002/slct.201904816] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
35 Anderson PM. Radiopharmaceuticals for Treatment of Osteosarcoma. Adv Exp Med Biol 2020;1257:45-53. [PMID: 32483729 DOI: 10.1007/978-3-030-43032-0_4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
36 Hernandez R, Grudzinski JJ, Aluicio-Sarduy E, Massey CF, Pinchuk AN, Bitton AN, Patel R, Zhang R, Rao AV, Iyer G, Engle JW, Weichert JP. 177Lu-NM600 Targeted Radionuclide Therapy Extends Survival in Syngeneic Murine Models of Triple-Negative Breast Cancer. J Nucl Med 2020;61:1187-94. [PMID: 31862799 DOI: 10.2967/jnumed.119.236265] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
37 Kaleağasıoğlu F, Zaharieva MM, Konstantinov SM, Berger MR. Alkylphospholipids are Signal Transduction Modulators with Potential for Anticancer Therapy. Anticancer Agents Med Chem 2019;19:66-91. [PMID: 30318001 DOI: 10.2174/1871520618666181012093056] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
38 Zhang RR, Grudzinksi JJ, Mehta TI, Burnette RR, Hernandez R, Clark PA, Lubin JA, Pinchuk AN, Jeffrey J, Longino M, Kuo JS, Weichert JP. In Silico Docking of Alkylphosphocholine Analogs to Human Serum Albumin Predicts Partitioning and Pharmacokinetics. Mol Pharm 2019;16:3350-60. [PMID: 31082240 DOI: 10.1021/acs.molpharmaceut.8b01301] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
39 Arlauckas SP, Browning EA, Poptani H, Delikatny EJ. Imaging of cancer lipid metabolism in response to therapy. NMR in Biomedicine 2018;32. [DOI: 10.1002/nbm.4070] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
40 Grudzinski JJ, Hernandez R, Marsh I, Patel RB, Aluicio-Sarduy E, Engle J, Morris Z, Bednarz B, Weichert J. Preclinical Characterization of 86/90Y-NM600 in a Variety of Murine and Human Cancer Tumor Models. J Nucl Med 2019;60:1622-8. [PMID: 30954941 DOI: 10.2967/jnumed.118.224808] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
41 Marsh IR, Grudzinski J, Baiu DC, Besemer A, Hernandez R, Jeffery JJ, Weichert JP, Otto M, Bednarz BP. Preclinical Pharmacokinetics and Dosimetry Studies of 124I/131I-CLR1404 for Treatment of Pediatric Solid Tumors in Murine Xenograft Models. J Nucl Med 2019;60:1414-20. [PMID: 30926646 DOI: 10.2967/jnumed.118.225409] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
42 Hernandez R, Walker KL, Grudzinski JJ, Aluicio-Sarduy E, Patel R, Zahm CD, Pinchuk AN, Massey CF, Bitton AN, Brown RJ, Sondel PM, Morris ZS, Engle JW, Capitini CM, Weichert JP. 90Y-NM600 targeted radionuclide therapy induces immunologic memory in syngeneic models of T-cell Non-Hodgkin's Lymphoma. Commun Biol 2019;2:79. [PMID: 30820474 DOI: 10.1038/s42003-019-0327-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 6.3] [Reference Citation Analysis]
43 Alam MW, Wahid KA, Goel RK, Lukong KE. Development of a low-cost and portable smart fluorometer for detecting breast cancer cells. Biomed Opt Express 2019;10:399-410. [PMID: 30800488 DOI: 10.1364/BOE.10.000399] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
44 Besemer AE, Grudzinski JJ, Weichert JP, Hall LT, Bednarz BP. Pretreatment CLR 124 Positron Emission Tomography Accurately Predicts CLR 131 Three-Dimensional Dosimetry in a Triple-Negative Breast Cancer Patient. Cancer Biother Radiopharm 2019;34:13-23. [PMID: 30351218 DOI: 10.1089/cbr.2018.2568] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
45 Grudzinski J, Marsh I, Titz B, Jeffery J, Longino M, Kozak K, Lange K, Larrabee J, Weichmann A, Moser A, Bednarz B. CLR 125 Auger Electrons for the Targeted Radiotherapy of Triple-Negative Breast Cancer. Cancer Biother Radiopharm 2018;33:87-95. [PMID: 29641256 DOI: 10.1089/cbr.2017.2376] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
46 Elsaid MY, Shahi A, Wang AR, Baiu DC, Li C, Werner LR, Singhal S, Hall LT, Weichert JP, Armstrong EA, Bednarz BP, Harari PM, Iyer G, Otto M. Enhanced Radiosensitivity in Solid Tumors using a Tumor-selective Alkyl Phospholipid Ether Analog. Mol Cancer Ther 2018;17:2320-8. [PMID: 30108133 DOI: 10.1158/1535-7163.MCT-17-0897] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
47 Bednarz B, Grudzinski J, Marsh I, Besemer A, Baiu D, Weichert J, Otto M. Murine-specific Internal Dosimetry for Preclinical Investigations of Imaging and Therapeutic Agents. Health Phys 2018;114:450-9. [PMID: 29481536 DOI: 10.1097/HP.0000000000000789] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
48 Jadvar H, Chen X, Cai W, Mahmood U. Radiotheranostics in Cancer Diagnosis and Management. Radiology 2018;286:388-400. [PMID: 29356634 DOI: 10.1148/radiol.2017170346] [Cited by in Crossref: 60] [Cited by in F6Publishing: 66] [Article Influence: 12.0] [Reference Citation Analysis]
49 Blanco VM, Chu Z, LaSance K, Gray BD, Pak KY, Rider T, Greis KD, Qi X. Optical and nuclear imaging of glioblastoma with phosphatidylserine-targeted nanovesicles. Oncotarget 2016;7:32866-75. [PMID: 27096954 DOI: 10.18632/oncotarget.8763] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
50 Zorniak M, Clark PA, Umlauf BJ, Cho Y, Shusta EV, Kuo JS. Yeast display biopanning identifies human antibodies targeting glioblastoma stem-like cells. Sci Rep 2017;7:15840. [PMID: 29158489 DOI: 10.1038/s41598-017-16066-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
51 Alam MM, Hassan AHE, Kwon YH, Lee HJ, Kim NY, Min KH, Lee S, Kim D, Lee YS. Design, synthesis and evaluation of alkylphosphocholine-gefitinib conjugates as multitarget anticancer agents. Arch Pharm Res 2018;41:35-45. [DOI: 10.1007/s12272-017-0977-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
52 Herrera FE, Sevrain CM, Jaffrès PA, Couthon H, Grélard A, Dufourc EJ, Chantôme A, Potier-Cartereau M, Vandier C, Bouchet AM. Singular Interaction between an Antimetastatic Agent and the Lipid Bilayer: The Ohmline Case. ACS Omega 2017;2:6361-70. [PMID: 30023517 DOI: 10.1021/acsomega.7b00936] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
53 Villa-Pulgarín JA, Gajate C, Botet J, Jimenez A, Justies N, Varela-M RE, Cuesta-Marbán Á, Müller I, Modolell M, Revuelta JL, Mollinedo F. Mitochondria and lipid raft-located FOF1-ATP synthase as major therapeutic targets in the antileishmanial and anticancer activities of ether lipid edelfosine. PLoS Negl Trop Dis 2017;11:e0005805. [PMID: 28829771 DOI: 10.1371/journal.pntd.0005805] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
54 Xiong H, Zuo H, Yan Y, Occhialini G, Zhou K, Wan Y, Siegwart DJ. High-Contrast Fluorescence Detection of Metastatic Breast Cancer Including Bone and Liver Micrometastases via Size-Controlled pH-Activatable Water-Soluble Probes. Adv Mater 2017;29. [PMID: 28563903 DOI: 10.1002/adma.201700131] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 8.0] [Reference Citation Analysis]
55 Baiu DC, Marsh IR, Boruch AE, Shahi A, Bhattacharya S, Jeffery JJ, Zhao Q, Hall LT, Weichert JP, Bednarz BP, Otto M. Targeted Molecular Radiotherapy of Pediatric Solid Tumors Using a Radioiodinated Alkyl-Phospholipid Ether Analog. J Nucl Med 2018;59:244-50. [PMID: 28747518 DOI: 10.2967/jnumed.117.193748] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
56 Besemer AE, Titz B, Grudzinski JJ, Weichert JP, Kuo JS, Robins HI, Hall LT, Bednarz BP. Impact of PET and MRI threshold-based tumor volume segmentation on patient-specific targeted radionuclide therapy dosimetry using CLR1404. Phys Med Biol 2017;62:6008-25. [PMID: 28682793 DOI: 10.1088/1361-6560/aa716d] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
57 Zhang RR, Schroeder AB, Grudzinski JJ, Rosenthal EL, Warram JM, Pinchuk AN, Eliceiri KW, Kuo JS, Weichert JP. Beyond the margins: real-time detection of cancer using targeted fluorophores. Nat Rev Clin Oncol 2017;14:347-64. [PMID: 28094261 DOI: 10.1038/nrclinonc.2016.212] [Cited by in Crossref: 263] [Cited by in F6Publishing: 280] [Article Influence: 43.8] [Reference Citation Analysis]
58 Chon H, Yoon K, Kwon DH, Kim CJ, Kim MS, Cho YH. Hypofractionated stereotactic radiosurgery for pituitary metastases. J Neurooncol 2017;132:127-33. [PMID: 28070828 DOI: 10.1007/s11060-016-2346-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
59 Gao M, Yu F, Lv C, Choo J, Chen L. Fluorescent chemical probes for accurate tumor diagnosis and targeting therapy. Chem Soc Rev 2017;46:2237-71. [DOI: 10.1039/c6cs00908e] [Cited by in Crossref: 512] [Cited by in F6Publishing: 527] [Article Influence: 85.3] [Reference Citation Analysis]
60 Garland M, Yim JJ, Bogyo M. A Bright Future for Precision Medicine: Advances in Fluorescent Chemical Probe Design and Their Clinical Application. Cell Chem Biol 2016;23:122-36. [PMID: 26933740 DOI: 10.1016/j.chembiol.2015.12.003] [Cited by in Crossref: 172] [Cited by in F6Publishing: 150] [Article Influence: 24.6] [Reference Citation Analysis]
61 Pointer KB, Clark PA, Eliceiri KW, Salamat MS, Robertson GA, Kuo JS. Administration of Non-Torsadogenic human Ether-à-go-go-Related Gene Inhibitors Is Associated with Better Survival for High hERG-Expressing Glioblastoma Patients. Clin Cancer Res 2017;23:73-80. [PMID: 27635088 DOI: 10.1158/1078-0432.CCR-15-3169] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
62 Zhang RR, Swanson KI, Hall LT, Weichert JP, Kuo JS. Diapeutic cancer-targeting alkylphosphocholine analogs may advance management of brain malignancies. CNS Oncol 2016;5:223-31. [PMID: 27616199 DOI: 10.2217/cns-2016-0017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
63 Clark PA, Al-Ahmad AJ, Qian T, Zhang RR, Wilson HK, Weichert JP, Palecek SP, Kuo JS, Shusta EV. Analysis of Cancer-Targeting Alkylphosphocholine Analogue Permeability Characteristics Using a Human Induced Pluripotent Stem Cell Blood-Brain Barrier Model. Mol Pharm 2016;13:3341-9. [PMID: 27421304 DOI: 10.1021/acs.molpharmaceut.6b00441] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
64 van der Have F, Ivashchenko O, Goorden MC, Ramakers RM, Beekman FJ. High-resolution clustered pinhole 131Iodine SPECT imaging in mice. Nuclear Medicine and Biology 2016;43:506-11. [DOI: 10.1016/j.nucmedbio.2016.05.015] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
65 Xiong H, Kos P, Yan Y, Zhou K, Miller JB, Elkassih S, Siegwart DJ. Activatable Water-Soluble Probes Enhance Tumor Imaging by Responding to Dysregulated pH and Exhibiting High Tumor-to-Liver Fluorescence Emission Contrast. Bioconjug Chem 2016;27:1737-44. [PMID: 27285307 DOI: 10.1021/acs.bioconjchem.6b00242] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 5.6] [Reference Citation Analysis]
66 Craig SEL, Wright J, Sloan AE, Brady-Kalnay SM. Fluorescent-Guided Surgical Resection of Glioma with Targeted Molecular Imaging Agents: A Literature Review. World Neurosurg 2016;90:154-63. [PMID: 26915698 DOI: 10.1016/j.wneu.2016.02.060] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
67 Arena F, Aime S, Blasi F. Contrast Media. PET-CT and PET-MRI in Neurology 2016. [DOI: 10.1007/978-3-319-31614-7_5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
68 Lubner SJ, Mullvain J, Perlman S, Pishvaian M, Mortimer J, Oliver K, Heideman J, Hall L, Weichert J, Liu G. A Phase 1, Multi-Center, Open-Label, Dose-Escalation Study of 131I-CLR1404 in Subjects with Relapsed or Refractory Advanced Solid Malignancies. Cancer Invest 2015;33:483-9. [PMID: 26536061 DOI: 10.3109/07357907.2015.1081691] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
69 Korb ML, Warram JM, Grudzinski J, Weichert J, Jeffery J, Rosenthal EL. Breast cancer imaging using the near-infrared fluorescent agent, CLR1502. Mol Imaging 2014;13. [PMID: 25743270 DOI: 10.2310/7290.2014.00040] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
70 Morris ZS, Weichert JP, Saker J, Armstrong EA, Besemer A, Bednarz B, Kimple RJ, Harari PM. Therapeutic combination of radiolabeled CLR1404 with external beam radiation in head and neck cancer model systems. Radiother Oncol 2015;116:504-9. [PMID: 26123834 DOI: 10.1016/j.radonc.2015.06.015] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
71 Swanson KI, Clark PA, Zhang RR, Kandela IK, Farhoud M, Weichert JP, Kuo JS. Fluorescent cancer-selective alkylphosphocholine analogs for intraoperative glioma detection. Neurosurgery 2015;76:115-23; discussion 123-4. [PMID: 25549194 DOI: 10.1227/NEU.0000000000000622] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 5.8] [Reference Citation Analysis]
72 Pickhardt PJ. Recent developments in colorectal imaging. Curr Opin Gastroenterol 2015;31:76-80. [PMID: 25394232 DOI: 10.1097/MOG.0000000000000141] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
73 Grudzinski JJ, Titz B, Kozak K, Clarke W, Allen E, Trembath L, Stabin M, Marshall J, Cho SY, Wong TZ, Mortimer J, Weichert JP. A phase 1 study of 131I-CLR1404 in patients with relapsed or refractory advanced solid tumors: dosimetry, biodistribution, pharmacokinetics, and safety. PLoS One 2014;9:e111652. [PMID: 25402488 DOI: 10.1371/journal.pone.0111652] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
74 Deming DA, Maher ME, Leystra AA, Grudzinski JP, Clipson L, Albrecht DM, Washington MK, Matkowskyj KA, Hall LT, Lubner SJ, Weichert JP, Halberg RB. Phospholipid ether analogs for the detection of colorectal tumors. PLoS One 2014;9:e109668. [PMID: 25286226 DOI: 10.1371/journal.pone.0109668] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]